Canadian Journal of Physiology and Pharmacology · 2019 · 21 citations · 16 references
Life SciencesEndocrinologyPharmacologyNeurochemistryNeuroendocrinologyStress PhysiologyAdrenal HormonesMonoamine NeurochemistryNeuroendocrine PhysiologySerotonergic SignalingStress EndocrinologyStress NeuroscienceAdrenal Medulla HormonesCatecholamine BiochemistryCatecholamine BiosynthesisChronic StressMelatonin TreatmentNorepinephrine BiosynthesisNorepinephrine SynthesisVesicular Monoamine Transporters
This study investigated the effects of melatonin treatment on adrenal catecholamine content, synthesis, uptake, and vesicular transport induced by the chronic unpredictable mild stress (CUMS) model of depression in rats. This entailed quantifying the norepinephrine, epinephrine, mRNA, and protein levels of tyrosine hydroxylase (TH), dopamine-β-hydroxylase (DBH), phenylethanolamine N-methyltransferase (PNMT), norepinephrine transporter (NET), and vesicular monoamine transporter 2 (VMAT2) in the adrenal medulla. CUMS caused a significant depletion of norepinephrine stores and protein levels of TH, DBH, and NET, whereas the gene expression of PNMT was increased. It was observed that melatonin treatment in the CUMS rats prevented the stress-induced decrease in norepinephrine content and the protein expression of TH, DBH, and NET in the adrenal medulla of chronically stressed rats. The present study demonstrates the stimulatory effect of melatonin on adrenomedullary synthesis, the uptake and content of catecholamine in the rat model of chronic stress-induced depression.
16
Karolina Szewczyk‐Golec, Paweł Rajewski, Marcin Gackowski et al. · Oxidative Medicine and Cellular Longevity · 2017 · 90 citations · Full text